Figure S3A show that the KL-6 level decreases gradually, and the lesion also diminishes in area and is absorbed during the in-hospital treatment in moderate COVID-19 patients while the KL-6 in severe patients maintains at high level. This evidence concerns the gene MUC1 and COVID-19.